Key result
Recent structural studies of Ryanodine and IP3 receptors provide functional insights that will aid in the development of rationale treatments for Ca(2+)-signaled malignancies.
Answers are grounded in this paper and cite their sources.
High-resolution structural mapping of Ryanodine receptors provides foundational insights into the mechanisms of skeletal and cardiomyocyte diseases caused by channel mutations.
Ryanodine receptors (RyRs) are the largest known ion channels. They are Ca(2+) release channels found primarily on the sarcoplasmic reticulum of myocytes. Several hundred mutations in RyRs are associated with skeletal or cardiomyocyte disease in humans. Many of these mutations can now be mapped onto the high resolution structures of individual RyR domains and on full-length tetrameric cryo-electron microscopy structures. A closely related Ca(2+) release channel, the inositol 1,4,5-trisphospate receptor (IP3 R), shows a conserved structural architecture at the N-terminus, suggesting that both channels evolved from an ancestral unicellular RyR/IP3 R. The functional insights provided by recent structural studies for both channels will aid in the development of rationale treatments for a myriad of Ca(2+)-signaled malignancies.
No takes yet. Share an insight, caveat, or question.
Amador et al. (2013) conducted a review in Skeletal or cardiomyocyte disease. Recent structural studies of Ryanodine and IP3 receptors provide functional insights that will aid in the development of rationale treatments for Ca(2+)-signaled malignancies.
Synapse has enriched 10 related papers. Consider them for comparative context: